[PDF] springer.com

Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment

Y Huang, X Li, L Yang - Stem Cell Research & Therapy, 2022 - Springer
Since December 2019, the coronavirus (COVID-19) pandemic has imposed huge burdens
to the whole world, seriously affecting global economic growth, and threatening people's …
被引用次数：9 相关文章 所有 11 个版本
[HTML] nih.govFull View

[HTML][HTML] Anti‐SARS‐CoV‐2 effect of extracellular vesicles released from mesenchymal stem cells

S Chutipongtanate, S Kongsomros… - Journal of …, 2022 - ncbi.nlm.nih.gov
As of 10 December 2021, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
accounted for 267 million people with up to 5.3 million deaths worldwide (https://covid19 …
被引用次数：29 相关文章 所有 7 个版本
[PDF] sagepub.comFull View

Mechanisms of potential therapeutic utilization of mesenchymal stem cells in COVID-19 treatment

Y Fang, P Lao, L Tang, J Chen, Y Chen… - Cell …, 2023 - journals.sagepub.com
The 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has
seriously affected the regular life trajectory of human beings. The severe acute respiratory …
被引用次数：5 相关文章 所有 7 个版本
[HTML] nih.gov

[HTML][HTML] Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment

L O'Driscoll - Drug discovery today, 2020 - ncbi.nlm.nih.gov
One of the hallmarks of coronavirus disease 2019 (COVID-19) is the so-called 'cytokine
storm'in response to the presence of severe acute respiratory syndrome coronavirus 2 …
被引用次数：50 相关文章 所有 3 个版本
[HTML] nih.gov

[HTML][HTML] Cellular therapy: the hope for covid-19

S Nobari, M Rezvan, F Dashtestani… - Avicenna Journal of …, 2022 - ncbi.nlm.nih.gov
Coronaviruses (CoVs) are a group of very diverse viruses that cause a broad spectrum of
diseases from mild to severe enteric, respiratory, systemic diseases, and common cold or …
被引用次数：6 相关文章 所有 13 个版本
[HTML] intechopen.com

Mesenchymal stem cells and extracellular vesicles: an emerging alternative to combat COVID-19

HC Rodriguez, M Gupta… - … to Combat COVID …, 2021 - books.google.com
The global SARS-CoV-2 outbreak has been accompanied with severe socioeconomic and
health burdens that will ripple through history. It is now known that SARS-CoV-2 induces a …
被引用次数：2 相关文章 所有 6 个版本
[PDF] springer.com

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali… - Stem cell research & …, 2021 - Springer
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …
被引用次数：47 相关文章 所有 17 个版本
[PDF] springer.com

Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs

E Jamshidi, A Babajani, P Soltani… - Stem Cell Reviews and …, 2021 - Springer
With the outbreak of coronavirus disease (COVID-19) caused by novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the world has been facing an …
被引用次数：46 相关文章 所有 5 个版本
[PDF] springer.com

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

A Tsuchiya, S Takeuchi, T Iwasawa, M Kumagai… - Inflammation and …, 2020 - Springer
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide …
被引用次数：79 相关文章 所有 13 个版本
[HTML] imrpress.com

[HTML][HTML] Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19

X Cheng, M Jiang, L Long, J Meng - Frontiers in Bioscience …, 2021 - imrpress.com
Background: Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious
disease caused by severe respiratory syndrome coronavirus 2 (SARS-CoV-2). The primary …
被引用次数：7 相关文章 所有 8 个版本